Quantcast

Latest Clinical research Stories

2014-07-02 23:11:59

Medrio’s M-1 is Ideal for Phase 1 Trials San Francisco, CA (PRWEB) July 02, 2014 Medrio, a provider of eClinical Software As A Service (SaaS) for clinical research, announced its M-1 product while an exhibitor at both DIA 2014 and BIO 2014. The two conferences brought together industry leaders across pharmaceutical and biotech fields for back to back weeks in San Diego. BIO and DIA’s positive impact on Medrio was evident as hundreds of companies, including sponsors and CROs, visited...

2014-07-02 23:05:52

Cognition is proud to announce Michelle Lott will be joining us as the Executive Advisor for Regulatory Strategy. Bedford, MA (PRWEB) July 02, 2014 Cognition is proud to welcome Michelle Lott as our Executive Advisor for Regulatory Strategy. Michelle’s input will help Cognition better understand regulatory requirements, the ever changing medical device industry standards, and the unique solutions that Cognition’s products like Cockpit provide. Cognition will leverage Michelle’s...

2014-07-02 23:03:52

MarketOptimizer.org adds “Paralysis Global Clinical Trials Review, H1, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Paralysis. Dallas, Texas (PRWEB) July 02, 2014 Clinical trial report, “Paralysis Global Clinical Trials Review, H1, 2014″ provides data on the Paralysis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Paralysis. It includes an overview of the...

2014-07-02 16:25:04

SEATTLE, July 2, 2014 /PRNewswire/ -- CMC Biologics, Inc., a global leader in process development and contract manufacturing, today announced that it has entered in to a Commercial Supply Agreement with Portola Pharmaceuticals, a biopharmaceutical company for the development of andexanet alfa, a potential first-in class Factor Xa inhibitor antidote in Phase 3 ANNEXA(TM) (Andexanet Alfa a Novel Antidote to the Anticoagulant Effects of fXA Inhibitors) studies. Andexanet alfa is...

2014-07-02 08:27:50

Expanding Contact-Free and Continuous Monitoring to Out-of-Bed Patients WALTHAM, Massachusetts, July 2, 2014 /PRNewswire/ -- EarlySense [http://www.earlysense.com ](R), the market leader in contact free monitoring solutions today announced the market clearance by the US Food and Drug Administration for the Chair Sensor Solution. The Chair Sensor, which continuously monitors patient's Heart Rate, Respiratory Rate and Movement, was recently evaluated at Coffee Regional Medical...

2014-07-02 08:26:29

REHOVOT, Israel, July 2, 2014 /PRNewswire/ -- Pharma Two B [http://www.pharma2b.com/en/Default.aspx ] announced today that the company's ongoing Phase IIb study of P2B001 for the treatment of early stage Parkinson's disease is now enrolling qualifying patients at 25 clinical sites throughout the US and Israel. Study details, site locations and contact people can be found here [http://clinicaltrials.gov/ct2/show/NCT01968460?term=P2B001&rank=1 ]. The study, titled A...

2014-07-01 23:07:44

AVERT™ Delivers Proven and Efficient Solution for Broad Assessment of Suicide Risk (PRWEB) July 01, 2014 ERT, a leading provider of technology solutions and services that increase the reliability and efficiency of high-quality patient data collection, today announced that the State of Oklahoma, Department of Mental Health and Substance Abuse Services (ODMHSAS) is implementing the AVERT™ Suicide Risk Assessment (SRA) system as a key component in its development of a public health...

2014-07-01 23:05:45

Transparency Market Research has published a new report titled "Clinical Trial Management System Market: Global Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/clinical-trial-management-systems-market.html. Albany, New York (PRWEB) July 01, 2014 According to a new market report published by Transparency Market Research "Clinical Trial Management System Market- Global...

2014-07-01 16:25:09

LONDON, July 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/drug_discovery/nasopharyngeal_cancer_global_clinical_trials_review_h1_2014.html Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014 SummaryGlobalData's clinical trial report, "Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Nasopharyngeal...

2014-07-01 08:30:55

DUBLIN, July 1, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/7xtphb/pharmacovigilance) has announced the addition of the "Global Pharmacovigilance (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) Market - Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 A rising tide of regulatory expectations, tougher inspection regime and instant need of patient reporting has...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.